MX2016003371A - Composiciones para el tratamiento de la hipertension y/o fibrosis. - Google Patents
Composiciones para el tratamiento de la hipertension y/o fibrosis.Info
- Publication number
- MX2016003371A MX2016003371A MX2016003371A MX2016003371A MX2016003371A MX 2016003371 A MX2016003371 A MX 2016003371A MX 2016003371 A MX2016003371 A MX 2016003371A MX 2016003371 A MX2016003371 A MX 2016003371A MX 2016003371 A MX2016003371 A MX 2016003371A
- Authority
- MX
- Mexico
- Prior art keywords
- fibrosis
- hypertension
- treatment
- compositions
- prophylactic
- Prior art date
Links
- 206010016654 Fibrosis Diseases 0.000 title abstract 2
- 206010020772 Hypertension Diseases 0.000 title abstract 2
- 230000004761 fibrosis Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- -1 terphenyl compound Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se relaciona con un compuesto novedoso y su uso en el tratamiento profiláctico y/o terapéutico de hipertensión y/o fibrosis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013903573A AU2013903573A0 (en) | 2013-09-17 | Compositions for the treatment of hypertension and/or fibrosis | |
| PCT/AU2014/000923 WO2015039173A1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016003371A true MX2016003371A (es) | 2016-10-21 |
| MX368865B MX368865B (es) | 2019-08-02 |
Family
ID=52687998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016003371A MX368865B (es) | 2013-09-17 | 2014-09-17 | Composiciones para el tratamiento de hipertension y/o fibrosis. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9458093B2 (es) |
| EP (1) | EP3046901B1 (es) |
| JP (1) | JP6122548B2 (es) |
| KR (1) | KR101736416B1 (es) |
| CN (1) | CN105683152B (es) |
| AP (1) | AP2016009079A0 (es) |
| AU (1) | AU2014324078B2 (es) |
| BR (1) | BR112016005601B1 (es) |
| CA (1) | CA2924356C (es) |
| DK (1) | DK3046901T3 (es) |
| ES (1) | ES2655455T3 (es) |
| IL (1) | IL244621A (es) |
| MX (1) | MX368865B (es) |
| MY (1) | MY172557A (es) |
| NO (1) | NO3046901T3 (es) |
| NZ (1) | NZ717927A (es) |
| PH (1) | PH12016500497B1 (es) |
| PL (1) | PL3046901T3 (es) |
| RU (1) | RU2635564C2 (es) |
| SG (1) | SG11201601642WA (es) |
| UA (1) | UA118111C2 (es) |
| WO (1) | WO2015039173A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3284981B2 (ja) | 1998-11-02 | 2002-05-27 | 株式会社デンソー | 車両用交流発電機およびそのステータの製造方法 |
| US9956166B2 (en) | 2013-09-18 | 2018-05-01 | Sorrento Therapeutics, Inc. | Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin |
| JP6734294B2 (ja) * | 2015-03-18 | 2020-08-05 | ヴェクタス バイオシステムズ リミテッド | 線維症及び線維症に関連する状態の処置のための組成物 |
| KR102554476B1 (ko) | 2015-03-18 | 2023-07-10 | 벡투스 바이오시스템즈 리미티드 | 신장 및／또는 간 질환 치료용 조성물 |
| CN112457280B (zh) * | 2015-09-22 | 2023-07-21 | 维克图斯生物系统有限公司 | 三联苯化合物的合成 |
| JP6980694B2 (ja) * | 2016-04-13 | 2021-12-15 | ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ | 投与のための方法およびレシニフェラトキシンで心血管疾患を治療する方法 |
| ES2965041T3 (es) | 2016-07-28 | 2024-04-10 | Vectus Biosystems Ltd | Composiciones para el tratamiento de la fibrosis pulmonar |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2694288B1 (fr) * | 1992-06-30 | 1994-09-09 | Rhone Poulenc Agrochimie | Phenylbenzamides fongicides et procédés pour les préparer. |
| NZ552130A (en) | 2004-06-11 | 2009-10-30 | Vectus Biosystems Ltd | Compositions and methods for the treatment of cardiovascular disease |
| ES2523858T3 (es) * | 2005-12-09 | 2014-12-02 | Vectus Biosystems Limited | Fragmentos de VIP y composiciones de los mismos |
| US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
| EP3046902B1 (en) * | 2013-09-17 | 2018-08-08 | Vectus Biosystems Limited | Compositions for the treatment of hypertension and/or fibrosis |
-
2014
- 2014-09-17 MY MYPI2016000482A patent/MY172557A/en unknown
- 2014-09-17 AU AU2014324078A patent/AU2014324078B2/en active Active
- 2014-09-17 EP EP14845373.1A patent/EP3046901B1/en active Active
- 2014-09-17 CA CA2924356A patent/CA2924356C/en active Active
- 2014-09-17 CN CN201480050979.1A patent/CN105683152B/zh active Active
- 2014-09-17 RU RU2016112257A patent/RU2635564C2/ru active
- 2014-09-17 WO PCT/AU2014/000923 patent/WO2015039173A1/en not_active Ceased
- 2014-09-17 ES ES14845373.1T patent/ES2655455T3/es active Active
- 2014-09-17 AP AP2016009079A patent/AP2016009079A0/xx unknown
- 2014-09-17 NO NO14845373A patent/NO3046901T3/no unknown
- 2014-09-17 UA UAA201602267A patent/UA118111C2/uk unknown
- 2014-09-17 US US15/022,278 patent/US9458093B2/en active Active
- 2014-09-17 DK DK14845373.1T patent/DK3046901T3/en active
- 2014-09-17 MX MX2016003371A patent/MX368865B/es active IP Right Grant
- 2014-09-17 PL PL14845373T patent/PL3046901T3/pl unknown
- 2014-09-17 JP JP2016515425A patent/JP6122548B2/ja active Active
- 2014-09-17 BR BR112016005601-9A patent/BR112016005601B1/pt active IP Right Grant
- 2014-09-17 SG SG11201601642WA patent/SG11201601642WA/en unknown
- 2014-09-17 KR KR1020167008664A patent/KR101736416B1/ko active Active
- 2014-09-17 NZ NZ717927A patent/NZ717927A/en unknown
-
2016
- 2016-03-14 PH PH12016500497A patent/PH12016500497B1/en unknown
- 2016-03-16 IL IL244621A patent/IL244621A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015010921A (es) | Compuestos de carbazol utiles como inhibidores de bromodominio. | |
| MX365614B (es) | Composiciones utiles para tratar trastornos relacionados con kit. | |
| MY176489A (en) | Novel tricyclic compounds as anticancer agents | |
| MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
| PH12016500497A1 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| PH12016500495A1 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| PH12017500836A1 (en) | Transdermal formulations | |
| MX345926B (es) | Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas. | |
| UA118670C2 (uk) | Способи та композиції для загоєння ран | |
| PH12017500348B1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| MY182818A (en) | Compositions for the treatment of fibrosis and fibrosis-related conditions | |
| GEP20207145B (en) | Combination of trazodone and gabapentin for the treatmen | |
| MX2013008559A (es) | Derivados de leptina. | |
| AU2013903573A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| AU2013903572A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| AU2013903571A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| IN2013CH05770A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |